Topics

Misonix Announces CE Mark Approval for Nexus

12:58 EDT 12 Aug 2019 | Investing News Network

Misonix (NASDAQ:MSON) has announced it has received CE Mark approval for its Nexus medical device. As quoted in the press release: The CE marking confirms that Nexus meets the requirements of the European Medical Devices Directive, which now allows Misonix to commercialize Nexus and its disposable products across the European Union and other CE Mark … Continued

The post Misonix Announces CE Mark Approval for Nexus appeared first on Investing News Network.

Original Article: Misonix Announces CE Mark Approval for Nexus

NEXT ARTICLE

More From BioPortfolio on "Misonix Announces CE Mark Approval for Nexus"

Quick Search